YU Dongqing, CHE Lu. Analysis of the relationships between CD62p, CD63 as well as platelet activating factor expression and clinical prognosis in patients with acute ischemic cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(19): 36-38. DOI: 10.7619/jcmp.20212694
Citation: YU Dongqing, CHE Lu. Analysis of the relationships between CD62p, CD63 as well as platelet activating factor expression and clinical prognosis in patients with acute ischemic cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(19): 36-38. DOI: 10.7619/jcmp.20212694

Analysis of the relationships between CD62p, CD63 as well as platelet activating factor expression and clinical prognosis in patients with acute ischemic cerebral infarction

More Information
  • Received Date: July 01, 2021
  • Available Online: September 23, 2021
  • Published Date: October 14, 2021
  •   Objective  To investigate the relationships between CD62p, CD63 as well as platelet activating factor (PAF) expression and clinical prognosis in patients with acute ischemic cerebral infarction (AICI).
      Methods  Two hundred AICI patients treated in our hospital were selected as observation group, and they were divided into good prognosis group (175 cases) and poor prognosis group (25 cases) according to their prognosis. According to the survival within 90 days after discharge, the observation group was divided into death group (n=32) and survival group(n=168). Fifty healthy people were selected as the control group. The correlations between CD62p, CD63, PAF and prognosis of patients was analyzed.
      Results  The levels of CD62p, CD63 and PAF in the observation group were significantly higher than those in the control group (P < 0.05). The levels of CD62p, CD63 and PAF in patients with cerebral infarction in the death group were significantly higher than those in the survival group (P < 0.05). The levels of CD62p, CD63 and PAF in patients with cerebral infarction in the poor prognosis group were significantly higher than those in the good prognosis group (P < 0.05).
      Conclusion  The expression levels of CD62p, CD63 and PAF increase in AICI patients, and detection of these three indicators is helpful to evaluate the clinical prognosis of patients.
  • [1]
    RABINSTEIN A A. Update on treatment of acute ischemic stroke[J]. Continuum: Minneap Minn, 2020, 26(2): 268-286. http://journals.lww.com/continuum/Abstract/2020/04000/Update_on_Treatment_of_Acute_Ischemic_Stroke.5.aspx
    [2]
    KUCZYNSKI A M, MARZOUGHI S, AL SULTAN A S, et al. Therapeutic hypothermia in acute ischemic stroke-a systematic review and meta-analysis[J]. Curr Neurol Neurosci Rep, 2020, 20(5): 13. doi: 10.1007/s11910-020-01029-3
    [3]
    潘晓帆, 秦琳, 周其达, 等. 急性缺血性脑卒中患者血小板膜糖蛋白的表达水平与临床伤残严重程度的相关性及其临床意义[J]. 卒中与神经疾病, 2019, 26(6): 681-684. doi: 10.3969/j.issn.1007-0478.2019.06.009
    [4]
    李伟, 张咪娟, 王琰, 等. 血小板活化因子和血管内皮活性标志物与腔隙性脑梗死的关系[J]. 华西医学, 2019, 34(10): 1143-1147. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYX201910010.htm
    [5]
    徐海滨, 付博文, 陈万莉, 等. 水摄取率在预测急性前循环大面积脑梗死患者恶性水肿发生中的价值[J]. 中华神经科杂志, 2020, 53(9): 681-686. doi: 10.3760/cma.j.cn113694-20200313-00173
    [6]
    王珊珊. 氯吡格雷对急性脑梗死合并糖尿病患者疗效及血清血管活性因子、血小板活化参数的影响[J]. 山东医药, 2019, 59(17): 51-53. doi: 10.3969/j.issn.1002-266X.2019.17.014
    [7]
    胡耀光, 徐俊峰, 黄俊凯. 银杏内酯注射液联合高压氧对急性缺血性脑卒中患者神经功能及血栓素血小板活化因子水平的影响[J]. 安徽医学, 2019, 40(4): 439-443. doi: 10.3969/j.issn.1000-0399.2019.04.025
    [8]
    孙逸夫, 肖成华, 陆军, 等. 急性脑梗死患者不同MS组分对其血小板聚集功能的影响及相关性研究[J]. 徐州医科大学学报, 2020, 40(3): 185-189. doi: 10.3969/j.issn.2096-3882.2020.03.006
    [9]
    冯真, 刘鹏. 阿司匹林联合氯吡格雷对急性脑梗死患者血小板活化及神经功能的影响[J]. 中国医院用药评价与分析, 2018, 18(6): 803-804, 807. https://www.cnki.com.cn/Article/CJFDTOTAL-YYPF201806030.htm
    [10]
    贾丽娜. 脑梗死患者血浆Hcy、ET-1、NSE及血小板活化指标与近期预后的关系[J]. 国际医药卫生导报, 2019, 25(15): 2527-2529. doi: 10.3760/cma.j.issn.1007-1245.2019.15.040
    [11]
    孟新颜, 耿德勤. 奥扎格雷联合葛根素治疗急性脑梗死患者的临床疗效及其对病灶侧支循环的影响[J]. 实用心脑肺血管病杂志, 2019, 27(10): 104-108. doi: 10.3969/j.issn.1008-5971.2019.10.020
    [12]
    聂珂, 赵嫦娇. 双联强化抗血小板对急性冠脉综合征合并糖尿病患者的血小板活性及预后影响[J]. 标记免疫分析与临床, 2019, 26(3): 380-384, 388. https://www.cnki.com.cn/Article/CJFDTOTAL-BJMY201903007.htm
    [13]
    王音, 侯丽淳, 王辰, 等. 急性脑梗死患者血清PAF、P选择素与颈动脉粥样硬化斑块稳定性的关系[J]. 中风与神经疾病杂志, 2018, 35(12): 1076-1078. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFSJ201812006.htm
    [14]
    汤卫忠, 殷诺, 潘海滨, 等. 血清PMP、CD62P和β-TG水平在预测急性脑梗死预后的临床价值[J]. 中国医药导刊, 2020, 22(4): 231-236. doi: 10.3969/j.issn.1009-0959.2020.04.005
    [15]
    DUMONTEIL N, LEVADE M, GARCIA C, et al. Platelet activation is limited during transcatheter aortic valve implantation in patients on aspirin monotherapy and without per procedural clinical complications[J]. TH Open, 2019, 3(2): e146-e152. doi: 10.1055/s-0039-1692142
    [16]
    WANG Y H, QIU H, HE X L, et al. Prevention of venous thromboembolism after resection of primary liver cancer with low molecular weight heparin and its association with P-selectin, lysosomal granule glycoprotein, platelet activating factor and plasma D-dimer[J]. Eur Rev Med Pharmacol Sci, 2018, 22(14): 4657-4662. http://www.ncbi.nlm.nih.gov/pubmed/30058703
  • Cited by

    Periodical cited type(6)

    1. 韩秀燕,许华,张沁丽. 血清尿酸水平与脑血管病因果关系的双向两样本孟德尔随机化研究. 实用临床医药杂志. 2025(01): 66-72 . 本站查看
    2. 罗丽,刘锋伟,马丹丹,张玮. 靳三针联合感觉统合训练治疗儿童语言障碍对语言功能及适应行为的影响. 实用中医药杂志. 2024(04): 749-751 .
    3. 刘洁洁,唐纯志. 靳三针疗法治疗痴呆Meta分析. 中国中医药图书情报杂志. 2024(04): 171-177 .
    4. 唐青青,李铁,李霞,杨宁,张世苹,张凯强,萨仁. 萨仁“南海调神”针法经验浅析. 中国针灸. 2024(10): 1177-1180 .
    5. 刘红喜,路梦颖,梁晓,魏竞竞,刘悦,陈云梦,迟显苏,付国静,张允岭. 基于髓海理论运用填精益髓法辨治中医脑病. 中医杂志. 2023(18): 1877-1884 .
    6. 杜明明,刘仕杰,宋金萍,谷慧敏. 补髓通窍益脑汤联合靳三针对血管性痴呆患者的影响. 光明中医. 2023(18): 3564-3566 .

    Other cited types(2)

Catalog

    Article views (388) PDF downloads (23) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return